Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Tetraphase in a multimillion-dollar licensing deal with Chinese Everest
February 21, 2018 Off

Tetraphase in a multimillion-dollar licensing deal with Chinese Everest

By Dino Mustafić

Tetraphase Pharmaceuticals which creates antibiotics to treat life-threatening multidrug-resistant (MDR) infections, has gotten a licensing agreement with Everest Medicines Limited,…

CARB-X launches its 2018 rounds of funding and invites applications
February 21, 2018 Off

CARB-X launches its 2018 rounds of funding and invites applications

By Dino Mustafić

CARB-X has announced its 2018 rounds of funding to support research into the development of antibiotics, vaccines, diagnostics, devices and…

Ritter Pharmaceuticals assigns specialist as it focuses on the first FDA-approved treatment for lactose intolerance
February 20, 2018 Off

Ritter Pharmaceuticals assigns specialist as it focuses on the first FDA-approved treatment for lactose intolerance

By Dino Mustafić

Ritter Pharmaceuticals will seek to do make sure its first pivotal Phase 3 clinical trial of RP-G28 for lactose intolerance…

Hikma’s CEO Darwazah continues as Executive Chairman, new CEO steps in to be located in London-based head office
February 20, 2018 Off

Hikma’s CEO Darwazah continues as Executive Chairman, new CEO steps in to be located in London-based head office

By Dino Mustafić

Hikma Pharmaceuticals has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer (CEO), who will also join Hikma’s Board of Directors…

Horizon Discovery has open vacancy, as the CEO steps down
February 20, 2018 Off

Horizon Discovery has open vacancy, as the CEO steps down

By Dino Mustafić

Horizon Discovery’s CEO Darrin M. Disley has decided to step down to “pursue other business interests”. To replace him temporarily,…

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
February 20, 2018 Off

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases

By Dino Mustafić

Shire, Microsoft and EURORDIS-Rare Diseases Europe want to handle together with the diagnostic challenge for patients living with a rare…

US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
February 19, 2018 Off

US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer

By Dino Mustafić

AstraZeneca and MedImmune, its global biologics research and development arm, got clearance from the FDA to have Imfinzi for the…

Creso formally enters Canadian market with the completion of Mernova acquisition
February 19, 2018 Off

Creso formally enters Canadian market with the completion of Mernova acquisition

By Dino Mustafić

Creso Pharma Limited has completed the acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova).

Celgene’s Otezla research showed Improvements for treating active behçet’s disease with oral ulcers
February 19, 2018 Off

Celgene’s Otezla research showed Improvements for treating active behçet’s disease with oral ulcers

By Dino Mustafić

Celgene Corporation said Monday that data from the phase III Relief clinical trial of Otezla in patients with active Behçet’s…

Apricus stocks fall down as its erectile dysfunction cream doesn’t satisfy the FDA
February 16, 2018 Off

Apricus stocks fall down as its erectile dysfunction cream doesn’t satisfy the FDA

By Dino Mustafić

Apricus Biosciences, a biopharmaceutical company urology and rheumatology focused drug-maker, will have to fire another shot at getting its topical cream…

Posts pagination

Previous 1 … 3,403 3,404 3,405 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine